Skip to main content

and
  1. Article

    Open Access

    cfDNA methylome profiling for detection and subty** of small cell lung cancers

    Small cell lung cancer (SCLC) is characterized by morphologic, epigenetic and transcriptomic heterogeneity. Subtypes based upon predominant transcription factor expression have been defined that, in mouse mode...

    Francesca Chemi, Simon P. Pearce, Alexandra Clipson, Steven M. Hill in Nature Cancer (2022)

  2. Article

    Open Access

    Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer

    Small cell lung cancer (SCLC) has a 5-year survival rate of <7%. Rapid emergence of acquired resistance to standard platinum-etoposide chemotherapy is common and improved therapies are required for this recalc...

    Maximilian W. Schenk, Sam Humphrey, A. S. Md Mukarram Hossain in Nature Communications (2021)

  3. No Access

    Article

    A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity

    Although small cell lung cancer (SCLC) is treated as a homogeneous disease, biopsies and preclinical models reveal heterogeneity in transcriptomes and morphology. SCLC subtypes were recently defined by neuroen...

    Kathryn L. Simpson, Ruth Stoney, Kristopher K. Frese, Nicole Simms in Nature Cancer (2020)

  4. Article

    Open Access

    Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

    Precision medicine aims to tailor cancer therapies to target specific tumor-promoting aberrations. For tumors that lack actionable drivers, which occurs frequently in the clinic, extensive molecular characteri...

    Pedro Torres-Ayuso, Sudhakar Sahoo, Garry Ashton, Elvira An in npj Genomic Medicine (2018)

  5. Article

    Open Access

    A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopy

    To develop a sensitive analytical method to quantify gemcitabine (2′,2′-difluorodeoxycytidine, dFdC) and its metabolites 2′,2′-difluorodeoxyuridine (dFdU) and 2′,2′-difluorodeoxycytidine-5′-triphosphate (dFdCT...

    Tashinga E. Bapiro, Frances M. Richards in Cancer Chemotherapy and Pharmacology (2011)

  6. No Access

    Article

    Maximizing mouse cancer models

  7. The laboratory mouse (Mus musculus) is one of the best model systems for investigations of cancer biology in vivo, ranging from basic models such as xenograft ...

  8. Kristopher K. Frese, David A. Tuveson in Nature Reviews Cancer (2007)

  9. No Access

    Chapter

    Tight Junction Proteins and Cancer

    The tight junction (TJ) has been the subject of intense investigations since its discovery in the early 1960s. It has long been recognized as a key determinant of the epithelial cell barrier function, but only...

    Isabel J. Latorre, Kristopher K. Frese, Ronald T. Javier in Tight Junctions (2006)

  10. No Access

    Article

    Discs-Large and Strabismus are functionally linked to plasma membrane formation

    During early embryogenesis in Drosophila melanogaster, extensive vesicle transport occurs to build cell boundaries for 6,000 nuclei. Here we show that this important process depends on a functional complex formed...

    Ok-Kyung Lee, Kristopher K. Frese, Jennifer S. James in Nature Cell Biology (2003)

  11. No Access

    Article

    Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein

    While PDZ domain-containing proteins represent cellular targets for several different viral oncoproteins, including human papillomavirus E6, human T-cell leukemia virus type 1 Tax, and human adenovirus E4-ORF1...

    Kristopher K Frese, Siu Sylvia Lee, Darby L Thomas, Isabel J Latorre in Oncogene (2003)